SAEs
malaria, deaths
MALARIA, ADVERSE REACTION
No Suspected Unexpected Serious Adverse Reaction (SUSARs) or deaths were reported. There were five SAEs throughout the trial, all due to severe malaria, not related to the vaccine, not life-threatening and did not lead to withdrawal. One (1) SAE was reported in Cohort 1 (21-45 years-old) and four (4) SAEs were reported in Cohort 2 (5-10 years-old). All resolved in less than two weeks.